Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice

Journal of Lipid Research

Volumn 41, Issue 2, 2000, Pages 253-259

  Tsukamoto, Kazuhisa ^a   Maugeais, Cyrille ^a   Glick, Jane M ^a   Rader, Daniel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apolipoprotein E; Gene transfer; Lipoprotein metabolism; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; FEMALE; GENE TRANSFER; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS E; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; LAC OPERON; LIPIDS; LIPOPROTEINS, VLDL; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN ISOFORMS; TRIGLYCERIDES;

EID: 0033999663     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mahley, R. W. 1988. Apolipoprotein K: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Kuipers, F., J. M. van Ree, M. H. Hofker, H. Wolters, G. In't Veld, R. Havinga, R. J. Vonk, H. M. G. Princen, and L. M. Havekes. 1996. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology. 24: 241-247.
3. Kuipers, F., M. C. Jong, Y. Lin, M. van Eck, R. Havinga, V. Blocks, H. J. Verkade, M. H. Hofker, H. Moshage, T. J. C. van Berkel, R. J. Vonk, and L. M. Havekes. 1997. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 100: 2915-2922.
4. Huang, Y., X. Q. Liu, S. C. J. Rall, J. M. Taylor, A. von Eckardstein, G. Assmann, and R. W. Mahley. 1998. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273: 26388-26393.
5. Tsukamoto, K., P. Smith, J. M. Glick, and D. Rader. 1997. Liver-directed gene transfer and prolonged expression of three major human apoE isoforms in apoE-defecient mice. J. Clin. Invest. 100: 107-114.
6. Borensztajn, J., M. S. Rone, and T. J. Kotlar. 1976. The inhibition in vivo of lipoprotein lipase (clearing factor lipase) activity by Triton WR 1339. Biochem. J. 156:539-543.
7. Tietge, U. J. F., A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussein, and D. J. Rader. 1999. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 40: 2134-2139.
8. Jeppesen, J., H. O. Hein, P. Snadicani, and F. Gyntelberg. 1998. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 97: 1029-1036.
9. Austin, M. A. 1991. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 11:2-14.
10. Ginsberg, H. N. 1997. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and sectrection of apolipoprotein B-containing lipoproteins from cultured liver cells. Clin. Exp. Pharmacol. Physiol. 24: A29-A32.
11. Pagnan, A., G. Zanetti, A. Bonanome, S. Biffanti, C. Ehnholm, L. Keso, and M. Lukka. 1987. Apolipoprotein E polymorphism, serum lipids and occurrence of "double pre-betalipoproteinemia" (DPBL) in subjects from two different populations. Atherosclerosis. 65: 23-28.
12. Bergeron, N., and R. J. Havel. 1996. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J. Clin. Invest. 97: 65-72.
13. Knouff, C., M. E. Hinsdale, H. Mezdour, M. K. Altenburg, M. Watanabe, S. H. Quarfordt, P. M. Sullivan, and N. Maeda. 1999. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103: 1579-1586.
14. Huang, Y., S. W. Schwendner, S. C. J. Rall, and R. W. Mahley. 1996. Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. J. Biol. Chem. 271: 29146-29151.
15. Huang, Y., S. C. J. Rall, and R. W. Mahley. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler. Thromb. Vasc. Biol. 17: 2817-2824.
16. van Vlijmem, B. J., K. W. van Dijk, H. B. van't Hof, P. J. van Gorp, A. van der Zee, H. van der Boom, M. L. Breuer, M. H. Hofker, and L. M. Havekes. 1996. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 ▶Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice. J. Biol. Chem. 271: 3059-30602.
17. Sullivan, P. M., H. Mezdour, S. H. Quarford, and N. Maeda. 1998. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2. Clin. Invest. 102: 130-135.
18. Gregg, R. E., L. A. Zech, E. J. Schaefer, and H. B. Brewer, Jr. 1981. Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotien E. Sceince. 211: 584-586.
19. Gregg, R. E., L. A. Zech, E. J. Schaefer, D. Stark, D. Wilson, and H. B. Brewer, Jr. 1986. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78: 815-821.
20. Hamilton, R. L., A. Moorehonse, and R. J. Havel. 1991. Isolation and properties of nascent lipoproteins from highly purified rat hepatocytic Golgi fractions. J. Lipid Res. 32: 529-543.
21. Fazio, S., M. F. Linton, A. H. Hasty, and I., F. Swift. 1999. Recycling of apolipoprotein E in mouse liver. J. Biol. Chem. 274: 8247-8253.
22. Gretch, D. G., S. L. Sturley, L. Wang, B. A. Lipton, A. Dunning, K. A. Grunwald, J. R. Welterau, Z. Yao, P. Talmud, and A. D. Attie. 1996. The amino terminus of apolipoprotein B is necessary but not sufficient for microsomal triglyceride transfer protein responsiveness. J. Biol. Chem. 271: 8682-8691.
23. Ji, Z. S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 101160-10167.
24. Cohn, J. S., M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, J. J. Genest, and J. Davignon. 1996. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 16: 149-159.
25. Strobl, W., N. L. Gorder, G. A. Fienup, Y. C. Lin-Leel A. M. J. Gotto, and W. Patsch. 1989. Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. J. Biol. Chem. 264: 1190-1194.
26. Srivastava, R. A. 1996. Regulation of the apolipoprotein E by dietary lipids occurs by transcriplional and post-transcriptional mechanisms. Mol. Cell. Biochem. 155: 153-162.
27. Salah, D., K. Bohnet, R. Gueguen, G. Siest, and S. Visvikis. 1997. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J. Lipid Res. 38: 904-912.